Sichuan Kelun Pharmaceutical Co., Ltd. Class A
002422
Rang in aandelen
#2010
Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and... Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, vein detained needles, nebulizer sets, and vacuum blood collection tubes; over-the-counter products; and APIs to treat cardiovascular, IPF, ED, anti-tumor, anti-emetic, antibiotic, VB12, anti-rheumatoid arthritis, multiple sclerosis, anti-schizophrenia, CKD and anti-anemia, polypeptide, and other indications. It also provides ambroxol hydrochloride, potassium chloride, sodium chloride, magnesium sulfate, glucose, sterile water, sodium bicarbonate, lidocaine hydrochloride, vitamin B6, ribavirin, ceftazidime, 5% glucose, and ceftriaxone sodium injections. In addition, the company engages in investment; import and export; enterprise management; logistics and transportation; business services; agricultural non-staple food processing; production and sale of pharmaceutical intermediates; research and development of bio-based materials technology; Internet and related services; crop planting; professional technical; biotechnology extension; socio-economic consultation; technology promotion; medical research and testing exhibition; general cargo road transport; ecological protection and environmental management; and wholesale and retail. It exports its products to Japan. The company was formerly known as Sichuan Kelun Pharmaceutical Factory Co., Ltd and changed its name to Sichuan Kelun Pharmaceutical Co., Ltd. in August 2003. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. operates as a subsidiary of Sichuan Kelun Industry Group CO., LTD.
Aandeelprijs
$6.40
Marktkapitalisatie
$10.19B
Verandering (1 dag)
-0.77%
Verandering (1 jaar)
27.14%
Land
CN
Handel Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Categorie
Healthcare
Operationele marge voor Sichuan Kelun Pharmaceutical Co., Ltd. Class A (002422)
Operationele marge op October 2026 TTM: 8.12%
Volgens de meest recente financiële rapporten en aandelenkoers van Sichuan Kelun Pharmaceutical Co., Ltd. Class A is de huidige operationele marge (TTM) 8.12%. Eind 2024 had het bedrijf een operationele marge van 20.29%.
Geschiedenis van de operationele marge van Sichuan Kelun Pharmaceutical Co., Ltd. Class A van 2007 tot 2026
Operationele marge aan het einde van elk jaar
| Jaar | Operationele Marge | Wijzigen |
|---|---|---|
| 2026 (TTM) | 8.12% | -25.98% |
| 2025 | 10.97% | -45.93% |
| 2024 | 20.29% | 19.14% |
| 2023 | 17.03% | 47.70% |
| 2022 | 11.53% | 50.92% |
| 2021 | 7.64% | 24.63% |
| 2020 | 6.13% | -15.33% |
| 2019 | 7.24% | -12.67% |
| 2018 | 8.29% | -18.08% |
| 2017 | 10.12% | 32.63% |
| 2016 | 7.63% | 3.25% |
| 2015 | 7.39% | -45.54% |
| 2014 | 13.57% | -19.27% |
| 2013 | 16.81% | -19.99% |
| 2012 | 21.01% | 1.99% |
| 2011 | 20.60% | 9.93% |
| 2010 | 18.74% | 20.36% |
| 2009 | 15.57% | 15.59% |
| 2008 | 13.47% | 10.86% |
| 2007 | 12.15% | 0.00% |
Operationele marge van vergelijkbare bedrijven of concurrenten
| Bedrijf | Operationele Marge | Verschil in operationele marge | Land |
|---|---|---|---|
| 38.59% | -95.25% |
US
|
|
| -149.01% | -118.35% |
US
|
|
| 25.57% | -96.85% |
AU
|
|
| 31.23% | -96.15% |
BE
|
|
| 28.81% | -96.45% |
NL
|
Wat is de Operationele marge van een bedrijf?
De Operationele marge is een belangrijke indicator om de winstgevendheid van een bedrijf te beoordelen. Hogere operationele marges zijn over het algemeen beter omdat ze aangeven dat een bedrijf zijn producten of diensten veel duurder kan verkopen dan de productiekosten. De Operationele marge wordt berekend door de winst van een bedrijf te delen door de omzet.